Search

Author/Creator Lichtenstein, Alan

1. A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation. (8th January 2015)

Authors:
Girnius, Saulius K.; Lee, Saem; Kambhampati, Suman; Rose, Michal G.; Mohiuddin, Abid; Houranieh, Antoun; Zimelman, Abraham; Grady, Terrence; Mehta, Paulette; Behler, Caroline; Hayes, Teresa G.; Efebera, Yvonne A.; Prabhala, Rao H.; Han, Andrew; Yellapragada, Sarvari V.; Klein, Catherine E.; Roodm...
Journal:
British journal of haematology
Issue:
Volume 169:Number 1(2015:Apr.)
Page Start:
36
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Mammalian Target of Rapamycin Inhibitors Induce Tumor Cell Apoptosis In Vivo Primarily by Inhibiting VEGF Expression and Angiogenesis. (28th February 2013)

Authors:
Frost, Patrick; Berlanger, Eileen; Mysore, Veena; Hoang, Bao; Shi, YiJiang; Gera, Joseph; Lichtenstein, Alan
Other Names:
Bjerkvig Rolf Academic Editor.
Journal:
Journal of oncology
Issue:
Volume 2013(2013)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗